Written Question · S7W-04068 · Session 7
Whether its Access to New Medicines Horizon Scanning Advisory Board is currently considering Friedreich’s ataxia and emerging treatments fo…
The question
To ask the Scottish Government whether its Access to New Medicines Horizon Scanning Advisory Board is currently considering Friedreich’s ataxia and emerging treatments for the condition, and, if so, which treatments are being monitored.
The answer
The Access to New Medicines Horizon Scanning Advisory Board (HSAB) identifies disruptive medicines which are predicted to have a significant impact on financial and/or service provision and provides recommendations on what will be required for their use should they be accepted for routine use in the NHS in Scotland.The HSAB is not currently assessing any medicines for Friedreich’s Ataxia, however new disease modifying treatments identified through horizon scanning, will be considered in line with established HSAB criteria for disruptive medicines.
In the Official Report
No contribution in the Official Report cites S7W-04068 by reference.